VectivBio Announces Successful Opening of US IND for Apraglutide for Acute Graft-Versus-Host Disease

NEXT STORY
electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
PREV STORY
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: FIT Biotech concludes the exploration of secondary listing to First North Sweden -not relevant at the moment

FIT Biotech Oy                                                             Company release 16.8.2018 at 4:30 PM EET FIT Biotech concludes the ...

author_avatar
NASDAQ Market News

Oncobiologics Announces Term Extension of Series A Warrants

CRANBURY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced ...

author_avatar
NASDAQ Market News

Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

The board of directors of Targovax ASA (the "Company"), has on 18 August 2017, ...

author_avatar
NASDAQ Market News